Consun Pharmaceutical trims outstanding shares via HKD 2.22 million buyback

Bulletin Express06-17

Consun Pharmaceutical Group Limited executed an on-market share repurchase on 17 June 2026, purchasing 168,000 ordinary shares for HKD 2.22 million at prices ranging between HKD 13.20 and HKD 13.24 per share. The volume-weighted average price was HKD 13.2185.

Following the transaction: • Issued shares (excluding treasury shares) decreased by 0.02 % from 840.01 million to 839.84 million. • Treasury share holdings rose from 1.54 million to 1.70 million shares, keeping total issued shares unchanged at 841.55 million.

Mandate utilisation and limits: • Repurchases are conducted under the mandate approved on 26 May 2026, which authorises the company to buy back up to 84.12 million shares. • Cumulative buybacks under this authority now total 1.36 million shares, equivalent to 1.62 % of the shares outstanding on the mandate date. • In line with Hong Kong listing rules, Consun Pharmaceutical is restricted from issuing new shares or selling treasury shares until 17 July 2026.

All repurchase procedures were confirmed as compliant with the Hong Kong Stock Exchange’s Main Board Rules and relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154111217?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154111217","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical trims outstanding shares via HKD 2.22 million buyback","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited executed an on-market share repurchase on 17 June 2026, purchasing 168,000 ordinary shares for HKD 2.22 million at prices ranging between HKD 13.20 and HKD 13.24 per share. The volume-weighted average price was HKD 13.2185.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.02 % from 840.01 million to 839.84 million.  \n• Treasury share holdings rose from 1.54 million to 1.70 million shares, keeping total issued shares unchanged at 841.55 million.</p>\n<p>Mandate utilisation and limits:\n• Repurchases are conducted under the mandate approved on 26 May 2026, which authorises the company to buy back up to 84.12 million shares.  \n• Cumulative buybacks under this authority now total 1.36 million shares, equivalent to 1.62 % of the shares outstanding on the mandate date.  \n• In line with Hong Kong listing rules, Consun Pharmaceutical is restricted from issuing new shares or selling treasury shares until 17 July 2026.</p>\n<p>All repurchase procedures were confirmed as compliant with the Hong Kong Stock Exchange’s Main Board Rules and relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical trims outstanding shares via HKD 2.22 million buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical trims outstanding shares via HKD 2.22 million buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-17 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited executed an on-market share repurchase on 17 June 2026, purchasing 168,000 ordinary shares for HKD 2.22 million at prices ranging between HKD 13.20 and HKD 13.24 per share. The volume-weighted average price was HKD 13.2185.</p>\n<p>Following the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.02 % from 840.01 million to 839.84 million.  \n• Treasury share holdings rose from 1.54 million to 1.70 million shares, keeping total issued shares unchanged at 841.55 million.</p>\n<p>Mandate utilisation and limits:\n• Repurchases are conducted under the mandate approved on 26 May 2026, which authorises the company to buy back up to 84.12 million shares.  \n• Cumulative buybacks under this authority now total 1.36 million shares, equivalent to 1.62 % of the shares outstanding on the mandate date.  \n• In line with Hong Kong listing rules, Consun Pharmaceutical is restricted from issuing new shares or selling treasury shares until 17 July 2026.</p>\n<p>All repurchase procedures were confirmed as compliant with the Hong Kong Stock Exchange’s Main Board Rules and relevant regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1154111217","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154111217","pubTimestamp":1781697944,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited executed an on-market share repurchase on 17 June 2026, purchasing 168,000 ordinary shares for HKD 2.22 million at prices ranging between HKD 13.20 and HKD 13.24...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业通过222万港元回购削减流通股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited executed an on-market share repurchase on 17 June 2026, purchasing 168,000 ordinary shares for HKD 2.22 million at prices ranging between HKD 13.20 and HKD 13.24 per share. The volume-weighted average price was HKD 13.2185.\nFollowing the transaction:\n• Issued shares (excluding treasury shares) decreased by 0.02 % from 840.01 million to 839.84 million.  \n• Treasury share holdings rose from 1.54 million to 1.70 million shares, keeping total issued shares unchanged at 841.55 million.\nMandate utilisation and limits:\n• Repurchases are conducted under the mandate approved on 26 May 2026, which authorises the company to buy back up to 84.12 million shares.  \n• Cumulative buybacks under this authority now total 1.36 million shares, equivalent to 1.62 % of the shares outstanding on the mandate date.  \n• In line with Hong Kong listing rules, Consun Pharmaceutical is restricted from issuing new shares or selling treasury shares until 17 July 2026.\nAll repurchase procedures were confirmed as compliant with the Hong Kong Stock Exchange’s Main Board Rules and relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154111217","isCrawlerRequest":true}